Skip to main content

Health Photos

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.
884 of 1871

Newsletter Sign Up

Daily Readings

Reading 1, Daniel 5:1-6, 13-14, 16-17, 23-28
King Belshazzar gave a great banquet for his noblemen, a ... Read More

Psalm, Daniel 3:62, 63, 64, 65, 66, 67
Bless the Lord, sun and moon, praise and glorify him for ever! ... Read More

Gospel, Luke 21:12-19
'But before all this happens, you will be seized and ... Read More

Saint of the Day

November 25 Saint of the Day

St. Catherine of Alexandria
November 25: St. Catherine of Alexandria, Virgin and Martyr whose feast day ... Read More